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Human Cytomegalovirus Infection of
Langerhans-Type Dendritic Cells Does Not
Require the Presence of the
gH/gL/UL128-131A Complex and Is Blocked
after Nuclear Deposition of Viral Genomes
in Immature Cells

Human Cytomegalovirus Infection of Langerhans-Type Dendritic Cells
Does Not Require the Presence of the gH/gL/UL128-131A Complex
and Is Blocked after Nuclear Deposition of Viral Genomes in
Immature Cells
‹Center for Immunobiology and Vaccine Development, Children’s Hospital Oakland Research Institute, Oakland, California, USAa; Department of Molecular Microbiology,
Washington University School of Medicine, St. Louis, Missouri, USAb

Human cytomegalovirus (CMV) enters its host via the oral and genital mucosae. Langerhans-type dendritic cells (LC) are the
most abundant innate immune cells at these sites, where they constitute a first line of defense against a variety of pathogens. We
previously showed that immature LC (iLC) are remarkably resistant to CMV infection, while mature LC (mLC) are more permissive, particularly when exposed to clinical-strain-like strains of CMV, which display a pentameric complex consisting of the viral
glycoproteins gH, gL, UL128, UL130, and UL131A on their envelope. This complex was recently shown to be required for the
infection of immature monocyte-derived dendritic cells. We thus sought to establish if the presence of this complex is also necessary for virion penetration of LC and if defects in entry might be the source of iLC resistance to CMV. Here we report that the
efficiency of LC infection is reduced, but not completely abolished, in the absence of the pentameric complex. While virion penetration and nuclear deposition of viral genomes are not impaired in iLC, the transcription of the viral immediate early genes
UL122 and UL123 and of the delayed early gene UL50 is substantially lower than that in mLC. Together, these data show that the
UL128, UL130, and UL131A proteins are dispensable for CMV entry into LC and that progression of the viral cycle in iLC is restricted at the step of viral gene expression.

M

yeloid dendritic cells (DC) are the most potent inducers of
adaptive immune responses (1, 2) and are highly abundant
in skin and mucosae, where they provide a first line of defense
against invading pathogens while simultaneously acquiring antigens for subsequent presentation to T and B lymphocytes (3, 4).
Tissue-resident myeloid DC are conventionally considered “immature” on the basis of their large antigen uptake capacity but
relatively low T-cell stimulatory ability. Activation by danger signals such as contact with pathogens or inflammatory cytokines
can then trigger their maturation and migration to the draining
lymph nodes, where, as mature DC, they can stimulate naive T and
B cells to proliferate and differentiate into effector T cells and
antibody-producing plasma cells, respectively (5). Despite playing
a critical role in the regulation of immunity, DC and their myeloid
precursors can themselves become means of infection with and
persistence and dissemination of numerous pathogens, including
human cytomegalovirus (CMV) (6).
CMV is a ubiquitous herpesvirus that can cause severe disease
in immunocompromised individuals, such as solid organ and
bone marrow transplant recipients, AIDS patients, and newborns
(7, 8). The oral, nasal, and genital mucosae are natural routes of
CMV acquisition and spread to new hosts via urine and saliva
(7–9). Mucosal DC residing at these anatomical locations are
among the first cell types to encounter CMV during entry and can
modulate the outcome of infection by contributing to virus dissemination during their migration toward the draining lymph
nodes and by stimulating the onset of adaptive immune responses
against CMV. Not surprisingly, myeloid DC are major targets of
CMV’s immunoevasive strategies aimed at damping and delaying
the proper onset of antiviral immune responses until latency is
established in hematopoietic progenitor cells (6, 10, 11).
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CMV reactivation from latency is also intrinsically linked to
the process of CD34⫹ and CD14⫹ cell differentiation into DC and
macrophages (12, 13), rendering tissue-resident DC an important
source of newly produced infectious virus (14–18). By reseeding
key tissues such as the salivary glands with reactivated virus, these
DC can effectively contribute to the horizontal transmission
of CMV.
Langerhans-type DC (LC) account for the totality of innate
immune cells residing in the epithelial layer of the oral mucosae,
while other types of myeloid DC, displaying surface markers similar to dermal DC, reside in deeper layers, including the lamina
propria and submucosa (19–22). DC populations morphologically, immunohistochemically, and ultrastructurally identical to
LC can be differentiated in vitro from CD34⫹ hematopoietic progenitor cells (23–26), while a type of DC considered by some to be
analogous to dermal CD14⫹ DC (25–27) and by others to be inflammatory cells distinct from resident, steady-state dermal DC
(28, 29) can be obtained from monocytes (monocyte-derived DC
[MDDC]).
These two types of DC differ substantially in their susceptibility

Received 17 October 2013 Accepted 18 October 2013
Published ahead of print 23 October 2013
Address correspondence to Laura Hertel, lhertel@chori.org.
* Present address: Dong Yu, Novartis Vaccines and Diagnostics, Cambridge,
Massachusetts, USA; Anthony R. Fehr, Department of Microbiology, University of
Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JVI.03062-13

Journal of Virology

p. 403– 416

jvi.asm.org

403

Downloaded from http://jvi.asm.org/ on January 28, 2014 by Washington University in St. Louis

Elvin J. Lauron,a Dong Yu,b* Anthony R. Fehr,b* Laura Hertela

Lauron et al.

MATERIALS AND METHODS
Cells. Human foreskin fibroblasts (HFF, a kind gift from E. S. Mocarski,
Emory University, Atlanta, GA) and ARPE-19 retinal pigment epithelial
cells (a gift from M. McVoy, Virginia Commonwealth University, Richmond, VA) were propagated in Dulbecco’s modified Eagle medium supplemented with 10% fetal clone serum III (HyClone), 100 U/ml penicillin,
100 g/ml streptomycin, 4 mM HEPES, and 1 mM sodium pyruvate
(Gibco, Life Technologies, Grand Island, NY). CD34⫹ hematopoietic
progenitor cells were magnetically separated with the CD34 MicroBead
kit (Miltenyi Biotec, Auburn, CA) from mononuclear cells obtained by
Ficoll-Hypaque density gradient centrifugation of peripheral blood samples collected in the Department of Hematology, Pediatric Sickle Cell
Program and Apheresis Program, Children’s Hospital & Research Center
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Oakland, Oakland, CA. iLC populations were obtained by culturing
CD34⫹ cells at a density of 1 ⫻ 104 to 2.5 ⫻ 104 per well in 48-well tissue
culture plates with serum-free X-VIVO 15 medium (Lonza/BioWhittaker, Allendale, NJ) supplemented with 1,500 IU/ml of granulocyte-macrophage colony-stimulating factor (GM-CSF, Leukine [sargramostim];
Immunex, Seattle, WA), 2.5 ng/ml of tumor necrosis factor ␣, 20 ng/ml of
stem cell factor, 100 ng/ml of Flt3 ligand, and 0.5 ng/ml of transforming
growth factor ␤1 (all purchased from Peprotech, Rocky Hill, NJ) for 10
days as previously described (30, 48, 49). mLC were subsequently obtained by exposing iLC to X-VIVO 15 medium containing 10% fetal bovine serum, 200 ng/ml of CD40 ligand (Immunex, Seattle, WA), 1,500
IU/ml of GM-CSF, and 250 ng/ml of lipopolysaccharide (Sigma-Aldrich,
St. Louis, MO) for 2 days.
Virus strains. AD169varATCC (50), originally purchased from the
American Type Culture Collection (ATCC), and Towne GFP-IE2, a green
fluorescent protein (GFP)-tagged derivative of TownevarRIT3 (51), were
gifts from E. S. Mocarski (Emory University, Atlanta, GA). TR-GFP, a gift
from D. Yu (Washington University, St. Louis, MO), was derived from
pTRgfp, a bacterial artificial chromosome (BAC) clone of the clinical isolate TR (52) carrying the BAC vector sequence juxtaposed to a loxP site in
place of the US2-5 region (53). In TR-GFP, the missing US2-5 region in
pTRgfp was repaired, a second loxP site was inserted to bracket the BAC
vector sequence for its excision during virus reconstitution, and a GFP
expression cassette was introduced for tracking of infection. This simian
virus 40 promoter-driven green fluorescent protein (GFP) expression cassette was inserted into the intergenic region between US7 and US8 and in
the same transcriptional orientation as these two ORFs to minimize potential interference with their expression. Reconstitution of the TR-GFP
virus, containing the full-length viral genome and expressing GFP, was
then done by electroporation of MRC-5 cells with 5 g of purified pTRgfp
BAC DNA and with 1 g each of expression plasmids encoding pp71 and
the Cre recombinase to promote the excision of the BAC vector sequence.
The US17 deletion mutant virus TRsubUS17 was derived from pTRgfp by
replacing the 882-bp sequence encoding US17 with a 2.3-bp GalK/kanamycin cassette (A. Fehr and D. Yu, unpublished). BADrUL131-Y4 (39), a
gift from M. McVoy (Virginia Commonwealth University, Richmond,
VA), was derived from a variant of the AD169 BAC clone BADwt (54)
containing the GFP sequence, an internal ribosomal entry site, the puromycin resistance gene in lieu of the UL21.5 ORF (55), and the wild-type
UL131A sequence from TR replacing the mutated original AD169 sequence (39). Escherichia coli bacteria harboring the BAC clones of CMV
strains TB40-BAC4 (56) and TB40-BAC4 UL128ccta82-86 were gifts
from C. Sinzger (University of Ulm, Ulm, Germany). UL128ccta82-86
was derived from TB40-BAC4 by replacing the nucleotide sequence encoding the charged amino acid cluster HSLTR of UL128 with the nucleotide sequence encoding the neutrally charged amino acid stretch ASLTA,
yielding a mutant virus incapable of assembling the gH/gL/UL128UL131A complex (43). Live virus was reconstituted by transfection of
BAC DNA in HFF with the Polyfect Transfection reagent in accordance
with the manufacturer’s instructions (Qiagen). Transfected cells were
maintained with regular medium changes until a 100% cytopathic effect
was observed. The supernatant was then harvested and used as the inoculum for virus amplification. All strains were propagated on HFF and
purified by ultracentrifugation as previously described (30). Virus titers
were determined by plaque assay on HFF monolayers in 24-well tissue
culture plates. Six (TB40-BAC4), four (TB40-BAC4 UL128ccta82-86),
three (BADrUL131-Y4), four (AD169varATCC), four (Towne GFP-IE2),
four (TR-GFP), and three (TRsubUS17) different stocks of each virus
were used for the experiments described. The identity of each strain was
verified by PCR amplification of viral DNA extracted from virion preparations with primers mapping to the UL128-UL131A locus, followed by
bidirectional sequencing of the DNA.
Cell infection. HFF and ARPE-19 cells were plated at a density of
⬃2 ⫻ 104/cm2 3 days before exposure to CMV at a multiplicity of infection (MOI) of 5 or 10 PFU/cell or to medium alone (mock). The virus

Journal of Virology

Downloaded from http://jvi.asm.org/ on January 28, 2014 by Washington University in St. Louis

to CMV infection in vitro. While immature LC (iLC) are remarkably resistant regardless of the virus strain (30), immature MDDC
(iMDDC) are fully permissive, but exclusively to infection by clinical-strain-like strains, which possess an extended tropism compared to that of laboratory-adapted strains (31–36). Both attenuated strain AD169varATCC and clinical-strain-like strain TB40/E
can initiate infection in mature LC (mLC), albeit with different
efficiencies (30), while the extent of permissiveness of mature
MDDC remains unclear (32, 33, 35, 36).
A pentameric complex that consists of the viral proteins gH,
gL, UL128, UL130, and UL131A and is displayed on the envelope
of endotheliotropic but not laboratory-adapted strains was recently shown to be required for virion entry into monocytes and
endothelial and epithelial cells (37–40). Strains naturally lacking
the expression of a functional UL131 (e.g., AD169varATCC),
UL130 (e.g., TownevarRIT3), or UL128 (e.g., Merlin) protein, as
well as viruses engineered to carry mutations in these open reading
frames (ORFs) (41–43), failed to initiate infection in all three cell
types, indicating that each of these proteins is individually required for tropism (37, 38, 44). All three gene products were also
shown to be indispensable for direct infection of iMDDC and for
virion transfer from infected human umbilical vein endothelial
cells to iMDDC (37, 45).
We previously showed that mLC can be productively infected
with AD169varATCC, a strain containing the gH/gL/gO, but not
the gH/gL/UL128-131A, complex on its envelope (46, 47). We
thus asked whether the pentameric complex is actually required
for CMV infection of LC. We found that both iLC and mLC could
be readily accessed by all of the strains tested, irrespective of the
gH/gL complex combination present on their envelopes, suggesting that the UL128-131A proteins are not essential for CMV entry
into LC.
Consistent with our previous findings (30), onset of productive infection in iLC remained extremely inefficient. To identify
the source of this resistance, the progress of infection in iLC was
compared to that in mLC. While no substantial difference was
observed in the proportion of penetrated virions or in the number
of viral genomes reaching the nucleus, the efficiency of UL122/
UL123 and UL50 ORF transcription was severely reduced in iLC,
leading to a nearly complete loss of expression of essential immediate early protein 1 (IE1) and IE2.
Together, these data show that CMV entry into iLC and mLC is
not restricted to strains harboring the gH/gL/UL128-131A complex on their envelopes and that infection progress in iLC is
blocked at the step of viral immediate early gene expression, with
negative consequences for the efficient progression of the viral
cycle.

CMV Infection of Langerhans Dendritic Cells
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anol, and air dried prior to prehybridization in FISH buffer for 30 min at
37°C in a humidified slide hybridization chamber. After the addition of 5
to 10 l of labeled probe, slides were incubated at 95°C for 2 min to
denature DNA. Hybridization was then carried out in a moist hybridization chamber overnight (18 to 20 h) at 37°C. Slides were subsequently
washed with 2⫻ SSC twice for 5 min at 60°C and once for 5 min at RT,
dried, and stained with Hoechst 33342 (0.2 mg/ml) for 3 min at RT. After
three washes in PBS, slides were mounted in ProLong Gold Antifade Reagent (Molecular Probes, Life Technologies, Grand Island, NY) and
viewed on a Zeiss LSM710 confocal inverted microscope equipped with
Zeiss ZEN image-processing software.
Real-time quantitative genomic PCR and reverse transcriptionPCR. Genomic DNA was extracted from infected HFF, ARPE-19 cells,
iLC, and mLC with the QIAamp DNA minikit (Qiagen, Valencia, CA).
mRNA was obtained from infected iLC and mLC with the MACS mRNA
isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany), treated with
DNase (DNA-free kit; Invitrogen, Life Technologies, Grand Island, NY)
to remove any contaminating genomic DNA, and reverse transcribed with
SuperScript II reverse transcriptase (Invitrogen, Life Technologies, Grand
Island, NY). Real-time quantitative PCRs were performed in triplicate
with iTaq SYBR green Supermix with ROX (Bio-Rad, Hercules, CA) and
an ABI7900 thermocycler (Applied Biosystems, Carlsbad, CA) with primers hybridizing to exon 2 of the viral UL122 and UL123 ORFs (forward
primer, 5=-GGCCGAAGAATCTCTCAAAA-3=; reverse primer, 5=-TCGT
TGCAATCCTCGGTCA-3=), to the viral UL50 ORF (forward primer, 5=AGAATTCATGGAGATGAACAAGGTT-3=; reverse primer, 5=-ACTCG
AGTCAGTCGCGGTGTGC-3=), or to the cellular albumin gene (forward
primer, 5=-GCTGTCATCTCTTGTGGGCTGT-3=; reverse primer, 5=-AA
ACTCATGGGAGCTGCTGGTT-3=). The following cycling parameters
were used: 95°C for 2 min to activate the iTaq polymerase, followed by 40
cycles of template denaturation at 95°C for 15 s, primer annealing at 51°C
(UL122/123 and UL50) or 57°C (albumin) for 30 s, and product extension
at 72°C for 30 s. Absolute quantifications of viral genome, viral transcript,
and cellular genome amounts were obtained by using a standard curve
made by serial dilutions of plasmid pON303 (61), a kind gift from E. S.
Mocarski (Emory University, Atlanta, GA), of plasmid LNCX UL50-HA
(62), and of a plasmid we constructed (pTOPO-albumin) that contains a
portion of the albumin gene corresponding to nt 16,000 to 16,500. The
number of viral genome copies per cell was then calculated as follows:
number of viral genome copies per cell ⫽ number of viral DNA copies/
(number of albumin DNA copies/2) (63).

RESULTS

The UL128-131A proteins are not required for CMV infection
of iLC and mLC. We previously showed that CMV strain
AD169varATCC can infect mLC, despite lacking the gH/gL/
UL128-131A complex. This suggested that the UL128-131A proteins might not be tropism determinants for this type of DC. To
test this idea, iLC and mLC populations differentiated from the
CD34⫹ progenitor cells of multiple donors were exposed to CMV
strains displaying different gH/gL complex combinations on their
envelopes and the efficiency of infection onset was assessed by
determining the percentage of cells expressing the IE1/IE2 proteins at 48 hpi. Infections of ARPE-19 epithelial cells were conducted in parallel for comparison. The strains used in this study
and their gH/gL envelope complexes are listed in Table 1. Briefly,
virions from the UL128mut, AD169, and Towne strains display
only the gH/gL/gO trimer (43, 46, 47, 64), while TR, BAC4, and
BADr particles harbor both the gH/gL/gO and gH/gL/UL128131A entry complexes (39, 40, 65).
To directly compare the infectious properties of each strain for
each cell type in an unbiased way, the following experimental conditions were implemented. First, all virus stocks were generated
and titers were determined in HFF, in order to standardize the
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inoculum was left in contact with cells at 37°C in 5% CO2 until the time of
harvest or for only 4 h. In the latter experiments, after removal of the
inoculum, cells were washed twice, treated with citrate buffer (40 mM
citric acid, 10 mM KCl, 135 mM NaCl, pH 3) for 1 min (min) at room
temperature (RT) to inactivate residual bound virus (57), washed again
twice, and incubated in fresh medium until harvest. At the end of the
differentiation (iLC) or maturation (mLC) period, LC were harvested,
counted, resuspended in fresh differentiation or maturation medium
again, and exposed to CMV at an MOI of 10 or 100 PFU/cell. The virus
inoculum was then left in contact with the cells until the time of harvest. In
selected experiments, after removal of the inoculum, cells were washed
twice in medium prior to treatment with citrate buffer as described above
or with 1 mg/ml of proteinase K for 1 h at 4°C to proteolytically remove
cell surface virions (58–60). Cells were then washed again twice, pelleted,
and stored at ⫺80°C for subsequent analyses or incubated in fresh medium until harvest.
IFA. For immunofluorescence staining analyses (IFA), HFF and
ARPE-19 cells were plated on 12-mm-diameter glass coverslips, while iLC
and mLC were harvested and deposited on glass slides by centrifugation at
800 rpm for 3 min at RT with a Cytospin 4 (Thermo Shandon). Cells were
fixed in 1% formaldehyde for 30 min at RT, permeabilized in 0.5% Triton
X-100 for 20 min on ice, and treated with blocking buffer (40% goat
serum– 40% fetal bovine serum in phosphate-buffered saline [PBS]) for
30 min at RT. Samples were then incubated with mouse monoclonal antibodies against the viral IE1/IE2 proteins (1:500, MAb810; Chemicon,
Temecula, CA) or against pp150 (1:400, originally from W. Britt, Birmingham, AL) for 1 h at RT in a humidified chamber, washed in blocking
buffer, and incubated with Alexa Fluor 594-conjugated goat anti-mouse
antibodies (1:500; Molecular Probes, Eugene, OR) for 1 h at RT. For dual
staining, cells were incubated in blocking buffer containing mouse monoclonal anti-pp150 antibodies and rabbit polyclonal anti-lamin B antibodies (1:50; Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at RT,
washed in blocking buffer, and incubated with Alexa Fluor 594-conjugated goat anti-mouse and Alexa Fluor 488-conjugated goat anti-rabbit
antibodies (1:500; Molecular Probes, Eugene, OR) for another hour at RT.
Nuclei were labeled with Hoechst 33342 (0.2 mg/ml; Molecular Probes,
Eugene, OR) for 3 min at RT. Slides were mounted in 90% glycerol–10%
PBS containing 2.5 g/liter of 1,4-diazabicyclo-(2,2,2)-octane (DABCO;
Alfa Aesar, Pelham, NH) prior to viewing on a Nikon Eclipse E600 fluorescence microscope equipped with iVision-Mac imaging software or on a
Zeiss LSM710 confocal inverted microscope equipped with Zeiss ZEN
image-processing software. Processing and three-dimensional reconstructions of confocal z-stack images were conducted with the Bitplane
Imaris Suite package of Scientific Volume Imaging (Hilversum, The Netherlands) and the Surpass Surfaces and the Surpass Section visualization
tools.
FISH assays. Probes consisted of a mixture of 10 pSC-B plasmids
(StrataClone Ultra Blunt PCR Cloning kit; Agilent Technologies, Santa
Clara, CA) containing the following DNA fragments from the genome of
CMV strain FIX-BAC (AC146907): nucleotides (nt) 69050 to 77680
(8,630 nt in length), 77680 to 86900 (9,220 nt), 86900 to 94700 (7,800 nt),
94400 to 102800 (8,400 nt), 136500 to 143600 (7,100 nt), 143300 to
150200 (6,900 nt), 149800 to 156800 (7,000 nt), 166400 to 173500 (7,100
nt), 173350 to 178000 (4,650 nt), and 178000 to 184700 (6,700 nt). Two
micrograms of a pSC-B plasmid mixture was labeled by nick translation in
the presence of 0.004 U of DNase I (New England BioLabs), 10 U of DNA
polymerase I (New England BioLabs), and 10 M ChromaTide Alexa
Fluor 594-5-dUTP (Molecular Probes, Eugene, OR) at 15°C for 75 min.
Labeled probes were then cleaned with the QIAquick Gel Extraction kit
(Qiagen, Valencia, CA) and resuspended in fluorescence in situ hybridization (FISH) buffer (2⫻ SSC [1⫻ SSC is 0.15 M NaCl plus 0.015 M
sodium citrate], 50% deionized formamide, 20% dextran sulfate).
iLC and mLC were harvested and deposited on glass slides by centrifugation as described above. Slides were then fixed in cold 95% ethanol–5% glacial acetic acid for 5 min at ⫺20°C, rinsed once in 100% eth-
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TABLE 1 Name and envelope complex composition of the CMV strains used in this study
ORF(s) deleted for
BAC insertion

AD169varATCC
Towne GFP-IE2

AD169
Towne

None
None

TR-GFP

TR-GFP

None

TRsubUS17

TRsubUS17

None

TB40-BAC4

BAC4

US2-US6

TB40-BAC4
UL128ccta82-86

UL128mut

US2-US6

BADrUL131-Y4

BADr

UL21.5

Origin

gH gL gO

gH gL UL128
UL130
UL131A

Plaque-purified derivative of ATCC stocks
GFP-IE2-expressing derivative of
TownevarRIT3
GFP-expressing derivative of TR-BAC
containing a full-length genome
TR-GFP derivative carrying the GalK/
kanamycin cassette in lieu of the US17
ORF
Highly endotheliotropic BAC clone of
TB40/E
BAC clone of TB40/E with the HSLTR
amino acid sequence of UL128 mutated
to ASLTA
BAC clone of AD169 with the UL21.5
ORF replaced with the GFP and
kanamycin resistance genes and the
original UL131A ORF replaced with the
UL131A ORF from strain TR

Yes
Yes

No
No

46, 47, 64
64

Yes

Yes

65

Yes

Yes

65

Yes

Yes

40, 65, 66

Yes

No

43

Yes

Yes

38

effects of the producer cell type on the tropism and entry modes of
the viral progeny (66, 67). HFF were chosen on account of their
abilities to support the growth of the AD169, Towne, and
UL128mut strains and to produce viral particles with a tropism
broader than that of those released by endothelial cells (66).
Second, at least three different stocks of each strain were tested,
in order to assess the robustness of each strain’s behavior and to
minimize the effect of adventitious mutations potentially arising
during CMV amplification in vitro. As the growth of clinicalstrain-like strains on HFF is associated with the relatively rapid
appearance of mutations in the ORFs encoding the UL128,
UL130, and UL131A proteins (68), the nucleotide sequence of the
UL128-131A genomic locus of each strain was verified by PCR
amplification and sequencing of virion DNA.
Third, infections were carried out in the absence of adsorptionenhancing treatments such as exposure to polyethylene glycol or
centrifugation to test the natural capacity of each strain to access
cells (59, 66, 69–72). Finally, viruses were left in contact with cells
until the time of harvest, in order to avoid the centrifugation step
required to remove the virus inoculum from LC cultures growing
in suspension.
Consistent with expectations (39), BAC4 and BADr expressed
the IE1/IE2 proteins in the majority of ARPE-19 cells, while
AD169, Towne, and UL128mut initiated infection in less than
0.5% of the cells (Table 2). In contrast, and contrary to published
data obtained with the TR strain (59), TR-GFP failed to infect cells
with high efficiency, despite carrying an intact UL128-131A locus.
To verify this finding, we tested the infectivity of a different TRGFP-derived virus, TRsubUS17, which lacks the ORF encoding
US17 (D. Yu, unpublished data). Although the function of US17 is
not known, this protein is not expected to be directly involved in
CMV tropism. Similar to TR-GFP, TRsubUS17 also inefficiently
infected ARPE-19 cells (Table 2), indicating that the observed
phenotype was not due to changes occurring during amplification
of the TR-GFP strain in our experiments and suggesting that other
viral determinants of tropism for epithelial cells are likely to exist
in addition to the UL128-131A proteins. Mutations in the ORF(s)
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Reference(s)
for virion
complex

encoding this as-yet-unidentified factor(s) and arising within the
TR-GFP genome would be maintained in the derived virus
TRsubUS17, producing identical phenotypes with respect to these
strains’ tropism for epithelial cells.
Consistent with our previous findings (30), mLC were overall
more permissive to infection than iLC were (Fig. 1A and B). Similar to ARPE-19 cells, BAC4 and BADr were more efficient than
UL128mut and AD169 at initiating infection in mLC, while TRGFP yielded the lowest percentage of IE1/IE2⫹ cells (Fig. 1B). As
the extent of infection was highly dependent on the donor of the
progenitor cells used to differentiate LC, the infectivities of strains
possessing or not possessing the gH/gL/UL128-131A complex
were compared in side-by-side infections of mLC derived from
the same donors (Fig. 1C and D). The percentage of infected mLC
observed after exposure to BAC4 was virtually identical to that
detected after exposure to UL128mut in cultures derived from 3 of
11 donors and 2- to 5-fold higher in the remaining cultures (Fig.
1C), with an overall median BAC4/UL128mut ratio of 2.3 ⫾ 1.5.
Similarly, the ratio of the percentages of BADr- and AD169-infected cells was ⬃1 for mLC derived from two of nine donors and
ranged between 1.4 and 2.6 for the rest of the cultures (Fig. 1D),
with a median value of 1.8 ⫾ 0.5.
Both TR-GFP and TRsubUS17 did not effectively enter mLC,
yielding percentages of IE1/IE2⫹ cells 3.5-fold (TR-GFP) and
TABLE 2 Percentages of IE1/IE2⫹ ARPE-19 cells after infection at an
MOI of 10
CMV strain

Median % of IE1/IE2⫹
ARPE-19 cells (SD)

No. of stocks
tested

No. of replicate
tests

BAC4
UL128mut
BADr
AD169
Towne
TR
TRsubUS17

48 (5.4)
0.02 (0.1)
100 (0)
0.24 (0.4)
0.12 (0.4)
1.81 (1.3)
2.53 (2)

3
2
2
3
3
4
3

3
5
6
18
5
8
5
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FIG 1 Efficiency of iLC and mLC infection by CMV strains carrying different entry complexes on their envelopes. (A and B) Percentages of IE1/IE2⫹ cells after

infection of iLC (A) or mLC (B) with different CMV strains at an MOI of 10 PFU/cell. Each symbol represents a separate donor of CD34⫹ progenitor cells used
to differentiate iLC and mLC populations. A horizontal bars marks the median value of each group. (C and D) Percentages of IE1/IE2⫹ cells obtained after
side-by-side infections of mLC derived from 11 (C) and 9 (D) different donors.

2-fold (TRsubUS17) lower than those observed after infection
with BAC4 (six donors). Similar to the situation in ARPE-19 cells,
TRsubUS17 was slightly more efficient than TR-GFP at initiating
infection of mLC, with a median TRsubUS17/TR-GFP ratio of
1.7 ⫾ 0.3 (nine donors).
Aside from being more resistant to infection, iLC responses to
each strain were largely similar to those of mLC, with BADr being
better than AD169, TRsubUS17 being better than TR-GFP, and
BAC4 being better than both TR-GFP and TRsubUS17 at initiating infection (Fig. 1A). In contrast to mLC, however, exposure to
BAC4 or UL128mut yielded virtually identical proportions of infected cells, with a median BAC4/UL128 ratio of 0.9 ⫾ 1.6 in
parallel infections of cultures derived from six donors.
Thus, absence of the gH/gL/UL128-131A complex from the
virion envelope effectively abolished viral entry into ARPE-19
cells and had essentially no impact on iLC infection but reduced
the efficiency of mLC infection by approximately 2-fold. These
data therefore indicate that, in contrast to epithelial cells, the presence of the UL128, UL130, and UL131A proteins is irrelevant for
viral entry into iLC and is advantageous but not essential for entry
into mLC. The low infectivity of TR-GFP for iLC, mLC, and
ARPE-19 cells, moreover, implies that other viral proteins besides
UL128, UL130, and UL131A may have a role in mediating CMV
tropism for epithelial cells and LC. Finally, the small but consistent difference between the efficiencies of infection of TR-GFP
and TRsubUS17 may hint at a potential role for US17 in restrain-

January 2014 Volume 88 Number 1

ing infection onset in LC and ARPE-19 cells, identifying this protein as a potential temperance factor (73).
CMV virion entry is not blocked in iLC. The fact that no viral
strain with the ability to initiate productive infection in iLC has
been found hints at the presence of host defense mechanisms that
cannot be overcome by any viral protein encoded by the strains
tested so far.
To identify the step in the viral cycle that is blocked in iLC, the
progress of viral particles was tracked by staining infected iLC and
mLC for pp150, a tegument phosphoprotein that remains
strongly associated with capsids during entry and has been used as
a capsid marker by us and others (60, 74, 75). Cytospin preparations of iLC and mLC exposed to BAC4 at an MOI of 10 PFU/cell
and harvested at 0.25, 1, 5, 20, and 30 hpi were fixed and permeabilized prior to the addition of anti-pp150 antibodies. The efficacy of permeabilization was verified by staining cells with antibodies against the nuclear envelope protein lamin B. While no
signal corresponding to pp150 was observed in mock-infected,
permeabilized iLC (Fig. 2A to C) or mLC (not shown), viral particles were clearly visible as bright dots (Fig. 2D and G) in infected
samples. At each of the times tested, the overall abundances of
viral particles appeared to be similar in infected iLC and mLC
(Fig. 2, compare D and G; data not shown). To precisely quantify
these data, the number of particles per cell observed in at least 200
cells from at least five different fields per time point was determined and the median number of virions per iLC versus the mLC
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to I) iLC and mLC populations differentiated from the progenitor cells of a
representative donor were left untreated (mock) or exposed to BAC4 at an
MOI of 10 PFU/cell. Cells were harvested at 0.25, 1, 5, 20, and 30 hpi, washed
once in medium, and centrifuged on glass slides. Samples were then fixed,
permeabilized, and stained for pp150 (left panels) and lamin B (middle panels). Nuclei were counterstained with Hoechst 33345 (right panels). (J) Median number of viral particles per mLC or per iLC observed in 280 to 1,170 iLC
found in 5 to 15 different microscopy fields and in 210 to 410 mLC found in 6
to 11 fields. Standard deviations and iLC/mLC ratios are shown. The dashed
line represents an iLC/mLC ratio of 1.

ratio was calculated (Fig. 2J). At 15 min postinfection, iLC and
mLC populations appeared to harbor similar numbers of particles/cell, with mean values of 4 ⫾ 1 for iLC and 4.6 ⫾ 1 for mLC
(Fig. 2J, 0.25 hpi), indicating that the efficiencies of virion attach-
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FIG 3 Viral genome contents of iLC and mLC at early times postinfection. iLC and mLC populations differentiated from the progenitor cells of four different

CD34⫹ cell donors were exposed to BAC4 at an MOI of 10 PFU/cell. At 0.25, 1, and 4 hpi, cells were collected, washed, and stored (untreated); washed and
exposed to citrate buffer to inactivate nonpenetrating viral particles; or washed and treated with proteinase K to remove extracellular virions. Real-time
quantitative PCR was then used to determine the number (n.) of viral genome copies per cell at each time postinfection (A) and to derive the ratio of the calculated
number of viral genome copies present in iLC to the number present in mLC (B).
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FIG 2 CMV particle density on iLC and mLC at early times postinfection. (A

ment and initial entry into the two cell types were highly comparable, albeit lower than expected for an MOI of 10 PFU/cell. At
both 1 and 5 hpi, mLC contained approximately 40% more particles than iLC did, but by 20 hpi, these differences had waned and
both cell types again contained similar number of particles. No
disparity was observed at 30 hpi either, although the total amount
of virions was greatly reduced from the beginning of infection,
potentially because of capsid disassembly after viral genome delivery into the nucleus. Thus, while mLC appeared to contain
slightly larger amounts of virions than iLC did at early times, similar number of particles were found in each cell type at later time
points, suggesting that virion entry into iLC is not dramatically
hindered.
As these assays did not allow us to distinguish between virions
attached to the cell surface and those that had already penetrated
the cell, we next treated infected cells with citrate buffer, which
was expected to inactivate and detach nonpenetrating virions the
cell from its surface (57, 76–78), or with proteinase K, which has
been reported to proteolytically remove residual extracellular particles (58–60). Real-time quantitative PCR was then used instead
of IFA to determine the number of viral genomes per cell under
each condition. iLC and mLC populations derived from the progenitor cells of four different donors were exposed to BAC4 at an
MOI of 10 PFU/cell for 15 min, 1 h, or 4 h. At each time point, cells
were collected, washed, and stored (untreated) or washed and
treated with citrate buffer for 1 min at room temperature or with
proteinase K for 1 h at 4°C. After additional washes, cells were
pelleted and subjected to real-time quantitative PCR with primers
hybridizing to the viral UL122/123 ORF (79) or to the cellular
albumin gene (63) and the number of viral genomes/cell was calculated.
At each of the time points tested, iLC contained slightly but
consistently larger amounts of viral DNA than mLC did (Fig. 3A,
white bars), with iLC/mLC ratios ranging from 2 ⫾ 1.5 at 15 min
postinfection to 3.8 ⫾ 1 at 4 h postinfection (Fig. 3B, white bars).
These values are higher than those obtained by IFA (Fig. 2J), likely
because of the superior precision of the quantification method
used (real-time PCR instead of manual counting), the testing of
cell populations derived from four different CD34⫹ cell donors
instead of one, and the tracking of viral genomes instead of viral
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A gradual decline in the cellular content of viral genomes was
observed in both LC types, irrespective of the strain used for infection (Fig. 4B, D, F, and H). This decrease was slightly more
pronounced in mLC than in iLC, which retained approximately
50% more input (4 hpi) viral DNA than mLC did at 48 hpi, on
average (Fig. 4J). As expected, because of the delayed CMV replication kinetics in mLC compared to those in HFF and ARPE-19
cells (30), no boost in viral DNA copy numbers was detected in
mLC at 48 hpi. The fact that expression of the IE1/IE2 proteins
could be detected at this same time point, however, indicates that
the viral replication cycle had successfully started in these cells.
In summary, no substantial difference was detected in the cellular content of viral genomes after infection of LC with strains
carrying functional or dysfunctional UL128-131A complexes, as
shown by the relatively small standard deviations in Fig. 4J compared to those of ARPE-19 cells in Fig. 4I. This suggests that LC
may process incoming virions from different strains in similar
ways, leading to comparable proportions of infected cells (Fig. 1)
and supporting the notion that the UL128, UL130, and UL131A
proteins are not essential for LC infection. The extent of viral
genome loss was larger in both LC types than in HFF or ARPE-19
cells (when exposed to BAC4 or BADr), but while enhanced genome loss may contribute to ARPE-19 cells’ resistance to infection
by certain strains (Fig. 4C and G), no obvious correlation could be
found between the extent of genome retention in LC and the proportion of IE1/IE2⫹ cells. Despite still containing 41% ⫾ 10% of
the input viral DNA at 48 hpi (Fig. 4J), only 3% ⫾ 2% of the iLC
(average of four donors) were IE1/IE2⫹ (Fig. 4J); in contrast, mLC
retained merely 20% ⫾ 11% of the initial viral genomes, and yet,
14% ⫾ 11% of them expressed the IE1/IE2 proteins. These data
suggest that increased genome loss due to the degradation of viral
DNA, the ejection of penetrated particles, or other unknown
mechanisms may contribute to the decreased permissiveness of
mLC compared to that of HFF or ARPE-19 cells but are not likely
to be the prime source of iLC resistance.
Nuclear deposition of CMV genomes is occurring in iLC. We
subsequently sought to establish if viral genomes did successfully
reach the nuclei of iLC or if, instead, they remained trapped in the
cell cytoplasm. High-magnification images of iLC harvested at 4
hpi with BAC4 and stained for pp150 showed the presence of
numerous virions in close proximity to the nucleus (Fig. 5A).
Confocal microscopy imaging further revealed the existence of
what appeared to be points of contact between some viral particles
and the outer surface of the nuclei of both iLC and mLC (Fig. 5B to
E, arrows), suggesting that capsids could successfully dock to the
nuclear envelope in both cell types. To determine if viral genomes
were subsequently deposited into the nucleus, cytospin preparations of LC infected with BAC4 and harvested at 24 hpi were
subjected to FISH labeling with probes hybridizing to the viral
genome. Bright dots corresponding to viral DNA could be detected within the nuclei of both iLC and mLC (Fig. 5D to G), with
no apparent difference between the two cell types with respect to
genome localization or the number of genomes per nucleus. In
fact, iLC and mLC samples could not be distinguished in blinded
analyses of FISH slides, suggesting that nuclear deposition of viral
genomes was occurring with similar efficiencies in both LC types.
The abundance of UL122/UL123 and UL50 transcripts is significantly lower in iLC. Finally, we sought to determine if transcription of the UL122/123 and UL50 ORFs was similarly efficient
in iLC and mLC. The UL122/123 ORF is expressed with immedi-
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capsids. Treatment of infected cells with citrate buffer did not
change the viral genome content of iLC and had only modest
effects (25, 10, and 17% decrease from untreated samples at 0.25,
1, and 4 h, respectively) on mLC (Fig. 3A, gray bars), suggesting
that, contrary to what was reported for other cell types (57, 76–
78), exposure to a low pH did not completely remove nonpenetrating virions from infected LC. Identical results were obtained
after iLC treatment with proteinase K, while enzymatic digestion
of mLC resulted in the removal of 55 to 64% of the bound virions
(Fig. 3A, black bars), consistent with what was previously reported
for monocytes, fibroblasts, and epithelial cells (58, 59). Viral particle attachment and internalization may thus occur more efficiently in iLC than in mLC. Already at 15 min postinfection, virtually all of the virions bound to iLC are protected from
proteolysis, presumably on account of their localization within
the cell’s interior. In contrast, only about 36 to 44% of the attached
particles are internalized by mLC at each of the time points tested,
suggesting that entry into mLC may be slower or less effective than
entry into iLC. Because of these differences, the intracellular content of viral particles was consistently higher (6.5-fold ⫾ 2-fold to
9-fold ⫾ 0.7-fold) in iLC than in mLC at each time postinfection
(Fig. 3B, black bars).
Together, these data indicate that virion entry into iLC occurs
with similar or better efficiencies than virion entry into mLC, suggesting that defects in binding and penetration are not the main
source of iLC resistance to infection.
Viral genome losses are similar in iLC and mLC. To determine if any difference might exist in the way viral particles are
processes by each LC type after penetration, the fate of viral genomes over time was tracked in HFF and ARPE-19 cells, used as
reference, and in iLC and mLC infected with BAC4, UL128mut,
BADr, and AD169 at an MOI of 10 PFU/cell. Cells were exposed to
each strain for 4 h before being washed with medium, treated with
citrate buffer to inactivate residual nonpenetrating virus, and
washed extensively again. Real-time quantitative PCR was then
used to determine the number of viral genomes present in each
cell population at 4, 8, 24, and 48 hpi and to calculate the proportion of genomes remaining at each time point relative to that at 4
hpi (Fig. 4), when the entry of noninternalized virions was halted
by low-pH treatment. The calculated average number of viral genomes per cell found in each population at 4 hpi averaged 2.6 ⫾
1.8 in iLC, 1.3 ⫾ 1.1 in mLC, 2.7 ⫾ 2 in ARPE-19 cells, and 3.1 ⫾
3 in HFF. Again, at this early time postinfection, iLC appeared to
hold more viral genomes than mLC did, while the viral DNA contents of HFF and ARPE-19 cells were almost identical.
As expected, all of the strains could efficiently infect HFF. The
content of viral DNA remained largely the same in these cells from
4 to 24 hpi, until the onset of viral replication caused it to increase
at 48 hpi (Fig. 4A, C, E, and G, dark gray bars). The same profile
was observed in ARPE-19 cells infected with BAC4 and BADr (Fig.
4A and E, light gray bars), while genomes from UL128mut and
AD169 were gradually lost over time with no amplification at 48
hpi (Fig. 4C and G, light gray bars). The detection of UL128mut
and AD169 genomes in ARPE-19 cell samples at the early time of
8 hpi clearly indicates that at least virion binding, if not also penetration, can occur in these cells in the absence of the gH/gL/
UL128-131A pentamer. The sharp drop in viral DNA amounts
observed later on, however, reveals that the entry route used by
these virions may not be viable, failing to lead to successful genome replication.
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FIG 4 Viral genome contents of HFF, ARPE-19 cells, iLC, and mLC at later times postinfection. Cells were exposed to BAC4, UL128mut, BADr, or AD169 virions
at an MOI of 10 PFU/cell for 4 h, washed in medium to remove the inoculum, and treated with citrate buffer to prevent any further virion penetration. A quarter
of the cells were then harvested immediately (4 hpi), while the rest were plated and harvested at 8, 24, and 48 hpi. Real-time quantitative PCR was used to
determine the number of viral genome copies per cell at each time point and to calculate the percentage of genomes remaining at 8, 24, and 48 hpi relative to that
at 4 hpi (% 4 hpi). (A, C, E, and G) Genomes remaining in ARPE-19 cells and HFF from one representative experiment, with the 48-hpi values shown on a log10
scale. (B, D, F, and H) Mean percentages of genomes remaining in iLC and mLC derived from four different CD34⫹ cell donors with standard deviations. (I and
J) Mean percentages of genomes remaining in each population after infection with BAC4, UL128mut, BADr, and AD169 with standard deviations. Values above
the columns at 48 hpi are the percentages of IE1/IE2⫹ cells obtained in IFA analyses of each cell type at 48 hpi.

ate early kinetics and encodes the IE1 and IE2 proteins essential for
infection onset (80–82), while the UL50 ORF is expressed with
early kinetics and encodes the nuclear egress complex component
UL50 (83–85). Real-time, quantitative reverse transcription-PCR
was used to determine the numbers of UL122/123 and UL50 transcript copies present in each cell type at 24, 48, and 72 h postexposure to AD169, BADr, BAC4, or UL128mut and to calculate the
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ratio of the number of cDNA copies of each gene present in the
mLC to the number of copies in the iLC of each donor (Fig. 6).
Although the UL122/123 ORF was expressed in both cell types,
mLC consistently contained more transcript copies than iLC at
each time point. Already at 24 hpi, the number of UL122/123
mRNA copies in mLC was 6 times (AD169 and BAC4), 8 times
(UL128mut), and 12 times (BADr) greater than that in iLC
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FIG 5 Localization of viral particles and genomes within iLC and mLC. Cells
were exposed to BAC4 at an MOI of 10 PFU/cell, harvested at 4 hpi (A to E) or
24 hpi (F to M), and processed by IFA with anti-pp150 antibodies (A to E) or
by FISH with probes hybridizing to the viral genome (F to M). (A) Superimposition of light and fluorescence images of an infected iLC. The signal from
pp150⫹ viral particles appears as sharp black dots. N, nucleus. Original magnification, ⫻60. (B to E) Confocal microscopy images of infected iLC and mLC
stained with anti-pp150 antibodies (red signal) and with Hoechst 33345 (light
blue signal). Merged z-stack images were processed with the Imaris Surpass
Surfaces visualization tool to create an artificial solid-object representation of
specified gray value ranges in the data set. Images are shown frontwise in panels
B and C and rotated leftwise and tilted at an ⬃45° angle in panels D and E. The
total z-stack thickness of the iLC sample was 2.45 m, while the mLC sample
measured 3.51 m. Arrows point at viral particles that appear to be in close
contact with the nuclear envelope. Original magnification, ⫻63. Bars, 5 m. (F
to M) Confocal microscopy images of infected iLC and mLC stained with a
ChromaTide Alexa Fluor 594-labeled probe hybridizing to multiple different
regions of the viral genome (red signal) and with Hoechst 33345 (light blue
signal). The merged images in panels F and J were processed with the Surpass
Section visualization tool to display the frontal (x, y, main square) and orthogonal (x, z, bottom rectangle) and (y, z, right rectangle) views of the z stack,
while the images in panels G to I and K to M were processed with the Surpass
Surfaces visualization tool and show nuclei frontwise in panels G and K, tilted
at an ⬃30° angle in panels H and L, and tilted at an ⬃90° angle in panels I and
M. The total z-stack thickness of both samples was 1.43 m. Original magnification, ⫻63.

(Fig. 6A, white bars). These differences further increased for two
donors at 48 hpi (43- and 40-fold in AD169-infected cells, 26- and
25-fold in BADr-infected cells) while remaining close to 5-fold for
the other two. An increase was also detected after infection with
BAC4 (14-fold) and UL128mut (10-fold) (Fig. 6A, light gray
bars). Finally, the ratios remained high at 72 hpi, with median
values of 10-fold (AD169) and 24-fold (BADr), while decreasing
back to 6-fold and 4-fold after infection with BAC4 and
UL128mut, respectively (Fig. 6A, dark gray bars).
Similar results were obtained for UL50 in LC populations derived from the CD34⫹ cells of two donors. Consistent with data
from infected fibroblasts (83), UL50 was expressed at 24 hpi in
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FIG 6 Ratios of UL122/123 and UL50 transcript amounts present in infected
iLC and mLC. mRNA extracted from cells exposed to AD169, BADr, BAC4, or
UL128mut at an MOI of 10 PFU/cell and harvested at 24, 48, and 72 hpi was
DNase treated and reverse transcribed. Quantitative real-time PCR assays were
then used to quantify the number (n.) of UL122/123 and UL50 cDNA copies
present in the equivalent of 1 ⫻ 102 iLC or mLC per reaction and to calculate
the ratio of the copy amounts found in mLC to those detected in iLC differentiated from the progenitor cells of three or four (UL122/123, A) and two
(UL50, B) different CD34⫹ progenitor cell donors. Each floating vertical bar
extends from the minimum to the maximum ratio obtained for the iLC and
mLC from different donors at each time point, while a horizontal bar marks
the median value of each group.

both LC types, albeit at different levels (median mLC/iLC ratios of
11 in AD169, 12 in BADr, 10 in BAC4, and 7 in UL128mut infections, Fig. 6B, white bars). While the number of UL50 mRNA
copies in mLC remained at least 5-fold higher than that in iLC at
each time point after infection with AD169 or BADr, differences
were somewhat lower at 72 h after infection with BAC4 and
UL128mut (Fig. 6B, dark gray bars). Considering that at both 24
and 48 h after infection with each strain, iLC contain more viral
genomes than mLC (Fig. 4B, D, F, and H) but substantially less
UL122/123 and UL50 mRNA copies (Fig. 6), transcription of viral
genes in iLC appears to be highly restricted. Together, these data
identify viral gene transcription as the first severely impaired step
in the regular progression of the viral cycle in iLC.
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fection than iLC are (Fig. 1) (30) is in stark contrast to the situation with MDDC, whereby immature cells, and not their mature
counterparts, are the most susceptible to CMV infection (33–36).
Despite being related and sharing many of the features and functions typical of antigen-presenting cells, LC and MDDC respond
to CMV in opposite ways, reflecting the heterogeneity and functional specialization of different DC populations. If these differences observed in vitro are also mirrored in vivo, then dermal DC
and epidermal LC are likely to play dramatically different roles in
the development of CMV pathogenesis and in the generation of
antiviral immune responses, a concept that may be relevant for the
development of live-attenuated vaccines intended for delivery via
mucosal surfaces.
None of the CMV strains tested so far has the ability to initiate
productive infections in iLC. This strongly supports the existence
of some iLC-specific defense mechanism that cannot be overcome
by any viral countermeasure. Intriguingly, while entry is the target
of multiple cellular antiviral strategies restricting infection in different cell types, CMV penetration of iLC is not blocked. Quite to
the contrary, data from our particle neutralization/detachment
experiments indicate that virion internalization is more efficient
in iLC than in mLC (Fig. 3A), leading to higher, instead of lower,
intracellular contents of virions at early times postinfection
(Fig. 3B).
This finding may not be that surprising in view of the wellknown superior antigen-capturing abilities of iLC, compared to
mLC (25, 90). While all three antigen internalization pathways,
namely, macropinocytosis, endocytosis, and phagocytosis, are
fully operational in iLC, two (macropinocytosis and phagocytosis) are downregulated during maturation (91, 92), leaving endocytosis as the predominant means of extracellular material acquisition by mLC. While our data suggest that CMV entry into mLC
may occur independently of vesicle-mediated transport pathways
(Fig. 1), the loss of two prominent entry routes following maturation may negatively impact the efficiency of CMV penetration of
these cells, at least in the case of pentamer-containing strains such
as BAC4.
Subsequent to entry, no major differences were detected between iLC and mLC in the kinetics of viral genome loss (Fig. 4J) or
in the number of viral genomes reaching the nucleus, arguing
against enhanced virion degradation or inefficient nuclear deposition of viral genomes as the main cause of iLC resistance to
infection. In contrast, the abundance of UL122/123 and UL50
ORFs transcripts was considerably lower in iLC than in mLC at
each of the times tested (Fig. 6), pointing at viral gene transcription as the first severely restricted step in the regular progression of
the viral cycle.
The most intriguing question now is how viral gene transcription is blocked in iLC. It is, of course, possible for iLC to express
higher levels of specific transcriptional repressors, whose binding
to the major immediate early promoter (MIEP) is followed by the
severe inhibition of UL122/123 expression. Conversely, mLC may
contain higher levels of transcriptional activators, whose positive
activity on the MIEP may promote the onset of lytic infection. The
resistance to CMV infection of undifferentiated human monocytic THP-1 cells, for instance, was found to be partially due to the
presence of the MBF1 and MRF transcriptional repressors in large
amounts (93, 94). Upon THP-1 differentiation into macrophages,
the abundance of both factors was substantially reduced, with a
concomitant increase in MIEP activity. This allowed the expres-
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Efficient CMV penetration of specific cell types requires fusion
of the virion envelope with cellular membranes in a process
controlled by both viral and cellular factors. Capsid release into
the cytoplasm can indeed occur at the periphery of the cell or
from intracellular vesicles, depending on the complement of
glycoprotein complexes displayed on the virion surface and on
the cell type.
The gH/gL/UL128-131A complex was shown to promote entry
by endocytosis and to be essential for the infection of epithelial
cells, endothelial cells, monocytes, and iMDDC (38, 40, 45, 59, 67,
86). Exposure to strains carrying only the gH/gL/gO complex was
not followed by viral gene expression in these cells, implying that
endocytosis is likely the predominant, if not the only, entry pathway conducive to productive infection onset.
Consistent with this, we found that viral DNA maintenance
and replication, as well as IE1/IE2 protein expression, in ARPE-19
epithelial cells occurred only after infection with strains possessing the pentameric complex and presumably entering by endocytosis (Table 2 and Fig. 4).
In contrast to the infection of epithelial cells, that of HFF does
not require expression of the UL128, UL130, and UL131A proteins but depends on the presence of the gH/gL/gO complex to
support fusion of the viral envelope with the plasma membrane
(46, 72, 87, 88). In our assays, penetration of HFF by virions from
strains possessing or lacking the gH/gL/UL128-131A complex
progressed equally well and led to the onset of productive infections (Fig. 4A, C, E, and G), suggesting that both entry modes may
be allowed to occur in this cell type. Alternatively, virions of
strains harboring both complexes on their envelope, such as BAC4
and BADr, may selectively use the trimeric complex to access HFF.
While the intracellular release of naked capsids at the cell periphery is considered to be the main entry route of CMV into these
cells (88), incoming virions were also detected within phagolysosome-like vacuoles in electron microscopic images of infected
cells (89), suggesting that endocytosis of viral particles can also
take place in HFF.
Here we show that the pentameric complex is not required for
infection of iLC and mLC, although in its presence, the efficiency
of mLC infection was increased by about 2-fold (Fig. 1). Similar to
the situation in HFF, strains containing both complexes or just
gH/gL/gO were equally able to bind to and likely enter both types
of LC, but their genomic DNA was subsequently lost (Fig. 4B, D, F,
and H), in a fashion comparable to that of UL128mut and AD169
in ARPE-19 cells (Fig. 4C and G). In contrast to the latter, however, the rate and extent of viral genome loss were similar for all
strains (Fig. 4J) and were not accompanied by a complete absence
of IE1/IE2 gene expression in mLC (Fig. 4J and 1B). It is thus
possible that, akin to HFF, both endocytosis and fusion with the
plasma membrane are viable routes of entry into iLC and mLC
and may be used interchangeably by virions possessing both complexes. When only the gH/gL/gO complex is present, particles may
still use both pathways to access cells, as suggested by the lack of
difference between the intracellular contents of viral DNA of different strains. Because the endocytic pathway is impracticable in
the absence of the pentameric complex, a portion of these virions
may fail to reach the nucleus, leading to a reduction in the percentage of IE1/IE2⫹ mLC.
Our finding that mLC are consistently more permissive to in-
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sion of the IE1/IE2 proteins and initiation of the viral replication
cycle to occur (93, 94). Epigenetically acting proteins such as histone acetyltransferases, histone deacetylases, and histone methyltransferases may also be potential players. In latently infected
CD34⫹ progenitor cells, the transcriptionally inactive UL122/123
promoter was indeed found to be associated with deacetylated H4
histones and with the transcriptional repressor heterochromatin
protein 1 (HP1), while in mLC derived from latently infected progenitors and harboring reactivating virus, the now active UL122/
123 promoter was associated with acetylated H4 histones and had
lost HP1 binding (15–17). Interestingly, and similar to our findings with directly infected iLC, no expression of the viral UL122/
123 ORFs was detected in iLC differentiated from latently infected
CD34⫹ cells, indicating that maturation is crucial for both infection onset and viral reactivation to occur. Thus, although CMV
reactivation in the CD34⫹-LC model was proposed to be “differentiation dependent” (95), we believe that it may be more tightly
linked to the process of maturation (i.e., “maturation dependent”). Interestingly, while differentiation and maturation of latently infected CD34⫹ progenitors into mLC trigger viral reactivation (15, 16), maturation of directly infected iLC has not yet
been reported to yield infectious virus. This suggests that the
mechanisms mediating silencing of the MIEP in iLC derived from
latently infected progenitors may be different from those acting
after direct infection of these cells.
Finally, mLC susceptibility to direct infection, as well as the
establishment of viral latency in CD34⫹ cells, was also proposed to
be regulated by the activity of nuclear domain 10 (ND10) bodies
(96), whose negative effects on MIEP transcription (97–99) can be
partially reversed by the nuclear delivery of the viral tegument
protein pp71 (100–105). Although no evidence was provided by
Saffert et al. as to the actual presence of viral genomes within the
ND10 bodies of infected CD34⫹ cells or mLC (96), pp71 appeared
to reach the nucleus in at least a few infected mLC. If incoming
viral genomes are indeed sequestered within the ND10 bodies of
iLC and if pp71 is subsequently prevented from reaching the nucleus, then silencing of the MIEP may remain in effect, preventing
the expression of the UL122/123 ORFs in these cells. On the other
hand, depletion of the ND10 component and the strong transcriptional repressor hDaxx from nonpermissive human teratocarcinoma T2 cells did not render them susceptible to infection (106),
and neither was their loss of resistance (triggered by exposure to
vasoactive intestinal peptide) accompanied by hDaxx degradation
(107), suggesting that the role played by hDaxx and pp71 in controlling CMV infection onset may be cell dependent and that they
may not be active in iLC.
Altogether, we postulate that iLC resistance to infection is
highly unlikely to depend on the activity of single cellular proteins.
Instead, multiple host defense effectors may cooperate in generating an unfavorable environment for viral gene transcription. Conversely, mLC susceptibility to CMV infection and reactivation
may depend on the assembly of an intranuclear milieu conducive
to MIEP activation and be characterized by the presence of selected transcription factors, the absence of others, and the occurrence of specific epigenetic modifications of the viral and cellular
genomes (95, 108). The relative contributions of some of these
elements to the regulation of LC susceptibility to infection are
under investigation.
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